News

2024 2006

2022.03.03 EPS Group EPS Holdings, Inc. and National Cancer Center Hospital East Signed Memorandum of Comprehensive Partnership （86754）
2022.02.14 EPS Group Web Seminar Held on Approaches to Achieve Patient-Centric Virtual/online Clinical Trials （349606）
2022.01.28 News Notice of Relocation: New Tsukudo Terrace Head Office Building is now open aiming to Create New Customer Value （199017）
2022.01.20 EPS Group Notice Regarding an Agreement for EPS Innovative Medicine (Japan) to Start Examining a Potential Joint Chinese Venture with FunPep Co., Ltd. （82294）
2021.12.24 IR Notice Regarding Partial Transfer of Shares of EPS Holdings Subsidiary （187409）
2021.12.20 EPS Group EPS Corporation Signs Business Partnership Agreement with OMRON Healthcare to Promote Virtual Clinical Trials （226530）
2021.12.10 EPS Group Speech on the Promotion of DCT at the Keidanren （122128）
2021.12.01 News Notice Regarding the New Management Structure for EPS Holdings, Inc. （120390）
2021.10.05 EPS Group Web Seminar Held for Pharmaceutical Companies and Academic Institutions Considering the Introduction of DDC （389633）
2021.10.04 Notice EPS is celebrating its 30th Anniversary （1863392）
2021.08.06 IR Consolidated Earnings Report for the First Nine Months of Fiscal 2021 （509728）
2021.07.09 IR Notice on Results of Tender Offer with Respect to the Shares of EPS Holdings, Inc. (Securities Code: 4282)
2021.07.01 EPS Group EP-SOGO starts Next-Generation Remote Source Document Verification (R-SDV) System to Streamline and Accelerate Clinical Trial Operations （436709）
2021.06.14 News EPS Holdings, Inc. will be exhibiting virtually at the DIA2021 Global Annual Meeting.
2021.06.02 IR Notice of Revision of Year-End Dividend Forecast for Fiscal Year Ending September 30, 2021 （199190）
2021.06.02 IR Notice Regarding Agreement with SUZUKEN Co., Ltd. on Capital Participation in Subsidiary of EPS Holdings, Inc. （208198）
2021.05.31 IR Financial Results Overview for the Second Quarter Ended March 31, 2021 （1260278）
2021.05.28 IR Notice Regarding MBO and Recommendation Application （1340034）
2021.05.28 IR Notice of Revision of Earnings Forecasts and Dividends of Surplus (30th Anniversary Commemorative Dividend （199190）
2021.05.12 IR Consolidated Earnings Report for the First Six Months of Fiscal 2021 （521076）